Changes in in vivo optical properties and light distributions in normal canine prostate during photodynamic therapy

Radiation Research

Volumn 147, Issue 1, 1997, Pages 86-91

  Chen, Qun ^a   Wilson, Brian C ^b   Shetty, Sugandh D ^c   Patterson, Michael S ^d   Cerny, Joseph C ^c   Hetzel, Fred W ^a  

^a Research and Development   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c HENRY FORD HOSPITAL   (United States)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSIMETRY; LIGHT; NONHUMAN; OPTICS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSTATE;

ANIMALS; BODY TEMPERATURE; DIHEMATOPORPHYRIN ETHER; DOGS; LIGHT; MALE; PHANTOMS, IMAGING; PHOTOCHEMOTHERAPY; PROSTATE; SCATTERING, RADIATION;

EID: 0031021897     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.2307/3579447     Document Type: Article

References (23)

1. B. W. Henderson and T. J. Dougherty, How does photodynamic therapy work? Photochem. Photobiol 55,145-157 (1992).
2. C. J. Gomer, A. Ferrario, N. Hayashi, N. Rucker, B. Szirth and A. L. Murphree, Molecular, cellular, and tissue responses following photo-dynamic therapy. Lasers Surg. Med. 8,450-463 (1988).
3. N. A. Buskard and B. C. Wilson, The use of photodynamic therapy in cancer. Semin. Oncol. 21(6),1-27 (1994).
4. M. L. Pantelides, C. Whitehurst, J. V. Moore, T. A. King and N. J. Blacklock, Photodynamic therapy for localized prostatic cancer: light penetration in the human prostate gland. J, Urol. 143,398-401 (1990).
5. S. H. Selman and R. W. Keck, The effect of transurethral light on the canine prostate after sensitization with the photosensitizer tin (II) etiopurpurin dichloride: a pilot study. J. Urol. 152,2129-2132 (1994).
6. S. Khoury, Future directions in the management of benign prostatic hyperplasia. Br. J. Urol. 1 (Suppl.),27-32 (1992).
7. A. D. Steinfeld, Questions regarding the treatment of localized prostate cancer. Radiology 184,593-598 (1992).
8. C. J. Mettline and G. Murphy, The National Cancer Data Base report on prostate cancer. Cancer 74,1640-1648 (1994).
9. M. S. Patterson, B. C. Wilson and R. Graff, In vivo tests of the concept of photodynamic threshold dose in normal rat liver photosensitized by aluminum chlorosulphonated phthalocyanine. Photochem. Photobiol. 51,343-349 (1990).
10. M. R. Arnfield, J. D. Chapman, J. Tulip, M. C. Penning and M. S. McPhee, Optical properties of experimental prostate tumors in vivo. Photochem. Photobiol. 57,306-311 (1993).
11. M. S. McPhee, C. W. Thorndyke, G. Thomas, J. Tulip, D. Chapman and W. H. Lakey, Interstitial applications of laser irradiation in hematoporphyrin derivative-photosensitized Dunning R3327 prostate cancers. Lasers Surg. Med. 4,93-98 (1984).
12. C. Whitehurst, M. L. Pantelides, J. V. Moore and N. J. Blacklock, Optimization of multifiber light delivery for the photodynamic therapy of localized prostate cancer. Photochem. Photobiol. 58,589-593 (1993).
13. L. K. Lee, C. Whitehurst, M. L. Pantelides and J. V. Moore, In situ comparison of 665 nm and 633 nm wavelength light penetration in the human prostate gland. Photochem. Photobiol. 62,882-886 (1995).
14. D. J. H. Roberts, F. Cairnduff, I. Driver, B. Dixon and S. B. Brown, Tumour vascular shutdown following photodynamic therapy based on polyhaematoporphyrin or 5-aminolaevulinic acid. Int. J. Oncol. 5,763-768 (1994).
15. T. J. Wieman, T. S. Mang, V. H. Fingar, T. G. Hill, M. W. R. Reed, T. S. Corey, V. Q. Nguyen and E. R. Render, Jr., Effect of photodynamic therapy on blood flow in normal and tumor vessels. Surgery 104,512-517 (1988).
16. I. Driver, C. P. Lowdell and D. V. Ash, In vivo measurement of the optical interaction coefficients of human tumours at 630 nm. Phys. Med. Biol. 36,805-813 (1991).
17. L. Lilge, T. Haw and B. C. Wilson, Miniature isotropic optical fibre probes for quantitative light dosimetry in tissue. Phys, Med. Biol. 38,215-230 (1993).
18. J. W. Pickering, C. J. M. Moes, H. J. M. C. Sterenborg, S. A. Prahi and M. J. C. van Gemert, Two integrating spheres with an intervening scattering sample. J. Opt. Soc. Am. A4,621-631 (1992).
19. B. C. Wilson, Measurement of tissue optical properties: methods and theories. In Optical-Thermal Response of Laser-Irradiated Tissue (A. J. Welch and M. J. C. van Gemert, Eds.), pp. 233-274. Plenum Press, New York, 1995.
20. B. J. Tromberg, A. Orenstein, S. Kimel, S. J. Barker, J. Hyatt, J. S. Nelson and M. W. Berns, In vivo tumor oxygen tension measurements for the evaluation of the efficiency of photodynamic therapy. Photochem. Photobiol 52,375-385 (1990).
21. J. P. Henning, R. L. Fournier and J. A. Hampton, A transient mathematical model of oxygen depletion during photodynamic therapy. Radial Res. 142,221-226 (1995).
22. T. H. Foster and L. Gao, Dosimetry in photodynamic therapy: Oxygen and critical importance of capillary density. Radiat, Res. 130,379-383 (1992).
23. A. Kienle, L. Lilge, I. A. Vitkin, M. S. Patterson and B. C. Wilson, Why do veins appear blue? A new look at an old question. Appl. Optics 35,1151-1160 (1996).